These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9348549)

  • 1. Neurobiology of tryptophan depletion in depression: effects of m-chlorophenylpiperazine (mCPP).
    Price LH; Malison RT; McDougle CJ; McCance-Katz EF; Owen KR; Heninger GR
    Neuropsychopharmacology; 1997 Nov; 17(5):342-50. PubMed ID: 9348549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroendocrine and behavioral responses to intravenous m-chlorophenylpiperazine (mCPP) in depressed patients and healthy comparison subjects.
    Anand A; Charney DS; Delgado PL; McDougle CJ; Heninger GR; Price LH
    Am J Psychiatry; 1994 Nov; 151(11):1626-30. PubMed ID: 7943451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neurobiology of tryptophan depletion in depression: effects of intravenous tryptophan infusion.
    Price LH; Malison RT; McDougle CJ; Pelton GH; Heninger GR
    Biol Psychiatry; 1998 Mar; 43(5):339-47. PubMed ID: 9513749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin function and depression: neuroendocrine and mood responses to intravenous L-tryptophan in depressed patients and healthy comparison subjects.
    Price LH; Charney DS; Delgado PL; Heninger GR
    Am J Psychiatry; 1991 Nov; 148(11):1518-25. PubMed ID: 1928466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin dysregulation in adolescents with major depression: hormone response to meta-chlorophenylpiperazine (mCPP) infusion.
    Ghaziuddin N; King CA; Welch KB; Zaccagnini J; Weidmer-Mikhail E; Mellow AM; Ghaziuddin M; Greden JF
    Psychiatry Res; 2000 Sep; 95(3):183-94. PubMed ID: 10974357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seasonal variation in neuroendocrine and mood responses to i.v. L-tryptophan in depressed patients and healthy subjects.
    Cappiello A; Malison RT; McDougle CJ; Vegso SJ; Charney DS; Heninger GR; Price LH
    Neuropsychopharmacology; 1996 Nov; 15(5):475-83. PubMed ID: 8914120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine response to meta-chlorophenylpiperazine and ipsapirone in relation to anxiety and aggression.
    Klaassen T; Riedel WJ; van Praag HM; Menheere PP; Griez E
    Psychiatry Res; 2002 Dec; 113(1-2):29-40. PubMed ID: 12467943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonergic and noradrenergic dysregulation in alcoholism: m-chlorophenylpiperazine and yohimbine effects in recently detoxified alcoholics and healthy comparison subjects.
    Krystal JH; Webb E; Cooney NL; Kranzler HR; Southwick SW; Heninger GR; Charney DS
    Am J Psychiatry; 1996 Jan; 153(1):83-92. PubMed ID: 8540598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central serotonergic effects of m-chlorophenylpiperazine (mCPP) among normal control adolescents.
    Ghaziuddin N; Welch K; Greden J
    Neuropsychopharmacology; 2003 Jan; 28(1):133-9. PubMed ID: 12496949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of sub-chronic administration of hydrocortisone on hormonal and psychological responses to L-tryptophan in normal male volunteers.
    Porter RJ; Gallagher P; Watson S; Lunn BS; Young AH
    Psychopharmacology (Berl); 2002 Aug; 163(1):68-75. PubMed ID: 12185402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of m-chlorophenylpiperazine after intravenous and oral administration in healthy male volunteers: implication for the pharmacodynamic profile.
    Feuchtl A; Bagli M; Stephan R; Frahnert C; Kölsch H; Kühn KU; Rao ML
    Pharmacopsychiatry; 2004 Jul; 37(4):180-8. PubMed ID: 15467976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissociable hormonal, cognitive and mood responses to neuroendocrine challenge: evidence for receptor-specific serotonergic dysregulation in depressed mood.
    Riedel WJ; Klaassen T; Griez E; Honig A; Menheere PP; van Praag HM
    Neuropsychopharmacology; 2002 Mar; 26(3):358-67. PubMed ID: 11850150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal and subjective responses to intravenous meta-chlorophenylpiperazine in bulimia nervosa.
    Levitan RD; Kaplan AS; Joffe RT; Levitt AJ; Brown GM
    Arch Gen Psychiatry; 1997 Jun; 54(6):521-7. PubMed ID: 9193192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonergic dissection of obsessive compulsive symptoms: a challenge study with m-chlorophenylpiperazine and sumatriptan.
    Gross-Isseroff R; Cohen R; Sasson Y; Voet H; Zohar J
    Neuropsychobiology; 2004; 50(3):200-5. PubMed ID: 15365215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. m-Chlorophenylpiperazine in patients with obsessive-compulsive disorder: absence of symptom exacerbation.
    Goodman WK; McDougle CJ; Price LH; Barr LC; Hills OF; Caplik JF; Charney DS; Heninger GR
    Biol Psychiatry; 1995 Aug; 38(3):138-49. PubMed ID: 7578657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of high-dose and low-dose tryptophan depletion on mood and cognitive functions of remitted depressed patients.
    Booij L; Van der Does AJ; Haffmans PM; Riedel WJ; Fekkes D; Blom MJ
    J Psychopharmacol; 2005 May; 19(3):267-75. PubMed ID: 15888512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin function in obsessive-compulsive disorder. A comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects.
    Charney DS; Goodman WK; Price LH; Woods SW; Rasmussen SA; Heninger GR
    Arch Gen Psychiatry; 1988 Feb; 45(2):177-85. PubMed ID: 3337615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroendocrine responses to m-chlorophenylpiperazine and L-tryptophan in bulimia.
    Brewerton TD; Mueller EA; Lesem MD; Brandt HA; Quearry B; George DT; Murphy DL; Jimerson DC
    Arch Gen Psychiatry; 1992 Nov; 49(11):852-61. PubMed ID: 1444722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of administration of mCPP on psychological, cognitive, cardiovascular, hormonal and MHPG measurements in human volunteers.
    Silverstone PH; Rue JE; Franklin M; Hallis K; Camplin G; Laver D; Cowen PJ
    Int Clin Psychopharmacol; 1994 Sep; 9(3):173-8. PubMed ID: 7814826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ritanserin antagonism of m-chlorophenylpiperazine effects in neuroleptic-free schizophrenics patients: support for serotonin-2 receptor modulation of schizophrenia symptoms.
    Abi-Saab W; Seibyl JP; D'Souza DC; Karper LP; Gueorgueva R; Abi-Dargham A; Wong ML; Rajhans S; Erdos JP; Heninger GR; Charney DS; Krystal JH
    Psychopharmacology (Berl); 2002 Jun; 162(1):55-62. PubMed ID: 12107618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.